4D Advisors’s Bio-Techne TECH Stock Holding History

4D Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,000	Closed	-$2.06M	–	46
2025 Q2	$2.06M	Buy	+40,000	New	+$2.01M	1.11%	33

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

4D Advisors's TECH Position: Q3 2025 in Review

4D Advisors sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 40,000 shares — an estimated $2.06M sold.

4D Advisors first reported a position in TECH in Q2 2025 and held it in 1 quarter. The position peaked at $2.06M in Q2 2025. 576 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

4D Advisors reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
4D Advisors sold 40,000 Bio-Techne shares in Q3 2025, an estimated $2.06M.
4D Advisors first reported a position in Bio-Techne in Q2 2025 and held it in 1 quarter.
4D Advisors's Bio-Techne position peaked at $2.06M in Q2 2025.
576 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on 4D Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.